288 related articles for article (PubMed ID: 20215532)
1. Targeting multiple kinase pathways: a change in paradigm.
Gossage L; Eisen T
Clin Cancer Res; 2010 Apr; 16(7):1973-8. PubMed ID: 20215532
[TBL] [Abstract][Full Text] [Related]
2. New paradigms in anticancer therapy: targeting multiple signaling pathways with kinase inhibitors.
Faivre S; Djelloul S; Raymond E
Semin Oncol; 2006 Aug; 33(4):407-20. PubMed ID: 16890796
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic protein kinase inhibitors.
Grant SK
Cell Mol Life Sci; 2009 Apr; 66(7):1163-77. PubMed ID: 19011754
[TBL] [Abstract][Full Text] [Related]
4. Protein kinases as targets for cancer treatment.
Giamas G; Stebbing J; Vorgias CE; Knippschild U
Pharmacogenomics; 2007 Aug; 8(8):1005-16. PubMed ID: 17716234
[TBL] [Abstract][Full Text] [Related]
5. Targeting cancer with small molecule kinase inhibitors.
Zhang J; Yang PL; Gray NS
Nat Rev Cancer; 2009 Jan; 9(1):28-39. PubMed ID: 19104514
[TBL] [Abstract][Full Text] [Related]
6. Challenges of developing therapeutics that target signal transduction in patients with gynecologic and other malignancies.
Rowinsky EK
J Clin Oncol; 2003 May; 21(10 Suppl):175s-186s. PubMed ID: 12743132
[TBL] [Abstract][Full Text] [Related]
7. PI3K and mTOR inhibitors: a new generation of targeted anticancer agents.
Brachmann S; Fritsch C; Maira SM; García-Echeverría C
Curr Opin Cell Biol; 2009 Apr; 21(2):194-8. PubMed ID: 19201591
[TBL] [Abstract][Full Text] [Related]
8. EGFR targeting therapies: monoclonal antibodies versus tyrosine kinase inhibitors. Similarities and differences.
Dassonville O; Bozec A; Fischel JL; Milano G
Crit Rev Oncol Hematol; 2007 Apr; 62(1):53-61. PubMed ID: 17324578
[TBL] [Abstract][Full Text] [Related]
9. Targeting the cancer kinome through polypharmacology.
Knight ZA; Lin H; Shokat KM
Nat Rev Cancer; 2010 Feb; 10(2):130-7. PubMed ID: 20094047
[TBL] [Abstract][Full Text] [Related]
10. [The signal transduction pathway of multi-target kinase inhibitors as anticancer agents in clinical use or in phase III].
Wu W; Lu C; Chen SY; Yu NF
Yao Xue Xue Bao; 2009 Mar; 44(3):242-57. PubMed ID: 19449520
[TBL] [Abstract][Full Text] [Related]
11. Dissecting kinase signaling pathways.
Boyle SN; Koleske AJ
Drug Discov Today; 2007 Sep; 12(17-18):717-24. PubMed ID: 17826684
[TBL] [Abstract][Full Text] [Related]
12. Targeting tumour-supportive cellular machineries in anticancer drug development.
Dobbelstein M; Moll U
Nat Rev Drug Discov; 2014 Mar; 13(3):179-96. PubMed ID: 24577400
[TBL] [Abstract][Full Text] [Related]
13. Targeting innate immunity protein kinase signalling in inflammation.
Gaestel M; Kotlyarov A; Kracht M
Nat Rev Drug Discov; 2009 Jun; 8(6):480-99. PubMed ID: 19483709
[TBL] [Abstract][Full Text] [Related]
14. Compensatory pathways in oncogenic kinase signaling and resistance to targeted therapies: six degrees of separation.
Trusolino L; Bertotti A
Cancer Discov; 2012 Oct; 2(10):876-80. PubMed ID: 23071031
[TBL] [Abstract][Full Text] [Related]
15. Targeting the Non-Catalytic Functions: a New Paradigm for Kinase Drug Discovery?
Wang Z; Huang W; Zhou K; Ren X; Ding K
J Med Chem; 2022 Feb; 65(3):1735-1748. PubMed ID: 35000385
[TBL] [Abstract][Full Text] [Related]
16. Kinase inhibitor conjugates.
Harmsen S; Kok RJ
Curr Pharm Des; 2012; 18(20):2891-900. PubMed ID: 22571658
[TBL] [Abstract][Full Text] [Related]
17. Targeting kinases with thymoquinone: a molecular approach to cancer therapeutics.
Afrose SS; Junaid M; Akter Y; Tania M; Zheng M; Khan MA
Drug Discov Today; 2020 Dec; 25(12):2294-2306. PubMed ID: 32721537
[TBL] [Abstract][Full Text] [Related]
18. Advances in targeting signal transduction pathways.
McCubrey JA; Steelman LS; Chappell WH; Sun L; Davis NM; Abrams SL; Franklin RA; Cocco L; Evangelisti C; Chiarini F; Martelli AM; Libra M; Candido S; Ligresti G; Malaponte G; Mazzarino MC; Fagone P; Donia M; Nicoletti F; Polesel J; Talamini R; Bäsecke J; Mijatovic S; Maksimovic-Ivanic D; Michele M; Tafuri A; Dulińska-Litewka J; Laidler P; D'Assoro AB; Drobot L; Umezawa D; Montalto G; Cervello M; Demidenko ZN
Oncotarget; 2012 Dec; 3(12):1505-21. PubMed ID: 23455493
[TBL] [Abstract][Full Text] [Related]
19. Advances in targeting insulin-like growth factor signaling pathway in cancer treatment.
You L; Liu C; Tang H; Liao Y; Fu S
Curr Pharm Des; 2014; 20(17):2899-911. PubMed ID: 23944362
[TBL] [Abstract][Full Text] [Related]
20. Targeting non-receptor tyrosine kinases using small molecule inhibitors: an overview of recent advances.
Hojjat-Farsangi M
J Drug Target; 2016; 24(3):192-211. PubMed ID: 26211367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
